Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis in a 15-Year-Old Patient After Receiving the Second Dose of the BBIBP-CorV (Sinopharm) COVID-19 Vaccine: A Case Report
Open Access
- 1 June 2022
- journal article
- research article
- Published by Brieflands in Nephro-Urology Monthly
- Vol. 14 (3)
Abstract
Introduction: Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is a group of multisystemic autoimmune diseases that can involve organs such as kidneys and respiratory tracts. Since the initiation of COVID-19 vaccines, there have been few cases of antineutrophil cytoplasmic antibody (ANCA) glomerulonephritis development after receiving vaccine doses. Case Presentation: This report describes a 15-year-old man who has developed ANCA-associated glomerulonephritis (AAGN) after receiving the second dose of BBIBP-CorV (Sinopharm) COVID-19 vaccine. Conclusions: Development of AAGN after both natural SARS-CoV-2 infection and following other vaccinations raises the question of the possible causality between the two. Considering the widespread use of COVID-19 vaccines, it is highly important to investigate their possible side effects.Keywords
This publication has 17 references indexed in Scilit:
- In-Depth Evaluation of a Case of Presumed Myocarditis After the Second Dose of COVID-19 mRNA VaccineCirculation, 2021
- ANCA glomerulonephritis after the Moderna COVID-19 vaccinationKidney International, 2021
- Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccineKidney International, 2021
- Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccinationKidney International, 2021
- ANCA-associated vasculitis after COVID-19Rheumatology International, 2021
- Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side EffectsVaccines, 2021
- Antineutrophil cytoplasmic antibodies‐associated glomerulonephritis: From bench to bedsideChronic Diseases and Translational Medicine, 2018
- ANCA Glomerulonephritis and VasculitisClinical Journal of the American Society of Nephrology, 2017
- ANCA-Associated Glomerulonephritis: Risk Factors for Renal RelapsePLOS ONE, 2016
- Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisationClinical Rheumatology, 2015